January Capital

January Capital is a Singapore-based data-driven venture firm with a primary thesis around B2B SaaS and commerce platforms across Asia-Pacific, with healthcare appearing as an opportunistic rather than core sector. Stage focus spans seed through Series B with checks in the $1M to $5M range, and AI is not flagged as a primary focus. The fund’s data-driven sourcing model creates a particular shape of engagement: deal flow is partly algorithmic, founders are often contacted by the team rather than the other way around, and the diligence process tends to be metric-heavy. The right founder for January Capital is an Asia-Pacific B2B SaaS or commerce operator with strong revenue retention, ARR growth, and gross margin clarity, where the healthcare business can be evaluated against the fund’s broader SaaS pattern recognition. Healthcare-specific founders should think of this as a SaaS investor that occasionally backs healthcare, not a healthcare specialist. The wrong founder is a deep medtech or therapeutics team, a consumer telehealth business without enterprise distribution, or any business whose unit economics do not read clearly through SaaS metrics. Intro paths run through Singapore’s tight enterprise SaaS community including Sequoia Surge alumni, Wavemaker Partners, and Insignia Ventures, through frequent co-investors such as Salesforce Ventures, Vertex Ventures, and Susquehanna’s APAC team, and through January Capital’s own portfolio CEOs. The fund’s data-driven outbound team also identifies companies directly, so being indexable on standard data sources matters more than for traditional VC. In the pitch, lead with ARR, NRR, gross margin, and CAC payback, all clearly stated and defended, and show a credible plan to scale across Asia-Pacific including Australia, where January Capital has historic strength. Be specific about your category positioning relative to comparable global SaaS comps and your data and AI architecture if relevant. Caveats are clarity-of-fit issues. January Capital is a strong partner for SaaS-shaped healthcare businesses but is unlikely to lean in on businesses where the SaaS metric translation is weak; founders should be honest about whether their model fits this lens before investing the time. For SaaS-native healthcare businesses, the fit is good and the partnership quality is high.